AR028525A1 - Sistema terapeutico transdermal para la administracion de lerisetron - Google Patents
Sistema terapeutico transdermal para la administracion de lerisetronInfo
- Publication number
- AR028525A1 AR028525A1 ARP010101463A ARP010101463A AR028525A1 AR 028525 A1 AR028525 A1 AR 028525A1 AR P010101463 A ARP010101463 A AR P010101463A AR P010101463 A ARP010101463 A AR P010101463A AR 028525 A1 AR028525 A1 AR 028525A1
- Authority
- AR
- Argentina
- Prior art keywords
- lerisetron
- therapeutic system
- transdermal therapeutic
- administration
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un preparado farmacéutico que contiene Lerisetron en forma de un sistema terapéutico transdermal (STT), el cual está constituido por una capa superior, un reservorio adhesivo de principio activo que contiene Lerisetron de al menos una capa unido a la capa superior, formado por uno o varios adhesivos de contacto de silicona, y una capa protectora amovible.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10015783A DE10015783C2 (de) | 2000-03-30 | 2000-03-30 | Transdermales therapeutisches System zur Abgabe von Lerisetron und seine Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028525A1 true AR028525A1 (es) | 2003-05-14 |
Family
ID=7636948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010101463A AR028525A1 (es) | 2000-03-30 | 2001-03-28 | Sistema terapeutico transdermal para la administracion de lerisetron |
Country Status (16)
Country | Link |
---|---|
US (1) | US20040001881A1 (es) |
EP (1) | EP1267846B1 (es) |
JP (1) | JP2003528912A (es) |
KR (1) | KR100624500B1 (es) |
AR (1) | AR028525A1 (es) |
AT (1) | ATE310510T1 (es) |
AU (1) | AU782487B2 (es) |
BR (1) | BR0109893A (es) |
CA (1) | CA2403949C (es) |
DE (2) | DE10015783C2 (es) |
ES (1) | ES2254425T3 (es) |
HU (1) | HUP0204448A3 (es) |
IL (2) | IL151922A0 (es) |
MX (1) | MXPA02009103A (es) |
NZ (1) | NZ521099A (es) |
WO (1) | WO2001074338A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
WO2003100091A1 (en) * | 2002-05-24 | 2003-12-04 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using 'setrones' |
GB0302662D0 (en) | 2003-02-05 | 2003-03-12 | Strakan Ltd | Transdermal granisetron |
FR2851470B1 (fr) * | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
JP2008511663A (ja) * | 2004-09-01 | 2008-04-17 | ネクスメツド・ホールデイングス・インコーポレイテツド | 経皮制吐送達系、そのための方法および組成物 |
DE102004044578A1 (de) | 2004-09-13 | 2006-03-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht |
US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
CN101287470B (zh) | 2005-10-12 | 2012-10-17 | 优尼麦德药物股份有限公司 | 改良的睾酮凝胶及使用方法 |
JP5333972B2 (ja) * | 2007-11-22 | 2013-11-06 | 株式会社 メドレックス | 脂肪酸系イオン液体を有効成分とする外用剤組成物 |
FR2943253B1 (fr) * | 2009-03-20 | 2011-04-22 | Oreal | Composition contenant l'association de madecassoside, d'une arginine et de polysorbate |
WO2010109544A1 (ja) * | 2009-03-27 | 2010-09-30 | 株式会社メドレックス | 核酸を有効成分とする外用剤組成物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
US5256665A (en) * | 1991-05-10 | 1993-10-26 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. | Process for preparing new 2-piperazinylbenzimidazole |
US5989586A (en) * | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
JPH10167956A (ja) * | 1996-12-11 | 1998-06-23 | Hisamitsu Pharmaceut Co Inc | セロトニン受容体拮抗薬含有経皮投与製剤 |
IT1294748B1 (it) * | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
GB9721139D0 (en) * | 1997-10-07 | 1997-12-03 | Glaxo Group Ltd | Medicaments |
US6136807A (en) * | 1998-11-10 | 2000-10-24 | 3M Innovative Properties Company | Composition for the transdermal delivery of lerisetron |
-
2000
- 2000-03-30 DE DE10015783A patent/DE10015783C2/de not_active Expired - Fee Related
-
2001
- 2001-03-17 IL IL15192201A patent/IL151922A0/xx active IP Right Grant
- 2001-03-17 AU AU62107/01A patent/AU782487B2/en not_active Ceased
- 2001-03-17 KR KR1020027011385A patent/KR100624500B1/ko not_active IP Right Cessation
- 2001-03-17 BR BR0109893-4A patent/BR0109893A/pt not_active Application Discontinuation
- 2001-03-17 CA CA002403949A patent/CA2403949C/en not_active Expired - Fee Related
- 2001-03-17 WO PCT/EP2001/003089 patent/WO2001074338A1/de active IP Right Grant
- 2001-03-17 AT AT01936095T patent/ATE310510T1/de not_active IP Right Cessation
- 2001-03-17 EP EP01936095A patent/EP1267846B1/de not_active Expired - Lifetime
- 2001-03-17 NZ NZ521099A patent/NZ521099A/en active Application Revival
- 2001-03-17 ES ES01936095T patent/ES2254425T3/es not_active Expired - Lifetime
- 2001-03-17 US US10/240,105 patent/US20040001881A1/en not_active Abandoned
- 2001-03-17 DE DE50108168T patent/DE50108168D1/de not_active Expired - Fee Related
- 2001-03-17 MX MXPA02009103A patent/MXPA02009103A/es unknown
- 2001-03-17 HU HU0204448A patent/HUP0204448A3/hu unknown
- 2001-03-17 JP JP2001572083A patent/JP2003528912A/ja not_active Withdrawn
- 2001-03-28 AR ARP010101463A patent/AR028525A1/es unknown
-
2002
- 2002-09-25 IL IL151922A patent/IL151922A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL151922A0 (en) | 2003-04-10 |
CA2403949A1 (en) | 2002-09-26 |
DE10015783A1 (de) | 2001-10-11 |
MXPA02009103A (es) | 2004-08-12 |
BR0109893A (pt) | 2003-04-01 |
DE10015783C2 (de) | 2003-12-04 |
KR100624500B1 (ko) | 2006-09-18 |
CA2403949C (en) | 2008-09-16 |
HUP0204448A3 (en) | 2004-07-28 |
ES2254425T3 (es) | 2006-06-16 |
AU6210701A (en) | 2001-10-15 |
EP1267846B1 (de) | 2005-11-23 |
JP2003528912A (ja) | 2003-09-30 |
HUP0204448A2 (en) | 2003-05-28 |
IL151922A (en) | 2007-10-31 |
KR20020084161A (ko) | 2002-11-04 |
AU782487B2 (en) | 2005-08-04 |
US20040001881A1 (en) | 2004-01-01 |
ATE310510T1 (de) | 2005-12-15 |
WO2001074338A1 (de) | 2001-10-11 |
NZ521099A (en) | 2006-11-30 |
EP1267846A1 (de) | 2003-01-02 |
DE50108168D1 (de) | 2005-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2581574T3 (es) | Sistema terapéutico transdérmico para la administración del principio activo buprenorfina | |
HK1069534A1 (es) | ||
HRP20050828B1 (hr) | Uv-stabilni transdermalni flaster | |
AR097045A2 (es) | Sistema terapéutico transdérmico | |
AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
BR0312573A (pt) | Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina | |
HN2001000224A (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos. | |
WO2006023644A3 (en) | Transdermal drug delivery device with translucent protective film | |
MX2009012273A (es) | Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica. | |
PA8594801A1 (es) | Formulaciones farmaceuticas liquidas de palanosetron | |
CO5640120A2 (es) | Formulacion y metodods para el tratamiento de trombocitemia | |
AR026040A1 (es) | Sistema terapeutico transdermal que contiene clorhidrato de tulobuterol para la administracion del broncodilatador tulobuterol a traves de la piel | |
CL2007002000A1 (es) | Preparacion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado que comprende portadores inertes, ingredientes activo, una capa interna compuesta de 2 capas de difusion para controlar la liberacion y una capa gastrorresistente; metodo de preparacion. | |
AR070031A1 (es) | Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas | |
MX2008008413A (es) | Composicion farmaceutica para el tratamiento de las enfermedades de las uñas. | |
ES2168241T1 (es) | Preparacion farmaceutica que contiene tolperisona para administrar por via oral. | |
CL2010000524A1 (es) | Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales. | |
AR026038A1 (es) | Sistema terapeutico transdermal para la administracion de acido acetilsalicilico y/o acido salicilico y proceso de fabricacion | |
BRPI0518554A2 (pt) | uso de um inibidor de pde3 | |
SE0103276D0 (sv) | Anordning för administrering av salva till en hudyta | |
WO2008097539A3 (en) | Multi-modal absorption, medicine-delivery lozenge, and use thereof | |
IS7383A (is) | Skammtaform með stýrða lyflosun til inngjafar | |
PE20060024A1 (es) | Sistema de administracion de principio activo formado por un parche, que contiene principio activo, y al menos un agente regulador de la administracion de principio activo | |
UY27920A1 (es) | Combinaciones de epinastina, pseudoefedrina y metilefedrina como nuevas formulaciones farmaceuticas | |
DE60312642D1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |